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Mucopolysaccharidosis type IH (MPS IH) is a rare autosomal recessive lysosomal storage disorder. Haematopoietic
stem cell transplantation (HSCT) has been proposed for the treatment of MPS IH patients and offers the possibility
to grow into their adulthood. Precocious puberty has been described in few MPS patients. We report, to the best of
our knowledge and for the first time, the initiation of the first waves of spermatogenesis fortuitously observed in
seminiferous tubules of a pre-pubertal 19-month-old boy, affected by MPS IH and who did not present any clinical
signs of precocious puberty. This patient benefited from testicular tissue cryopreservation before HSCT. Seminiferous
tubule size, germ cell differentiation and Sertoli cell expression of androgen receptor and anti-müllerian hormone
corresponded to the pattern observed in a pubertal boy. The Hurler syndrome may be responsible for the precocious
initiation of spermatogenesis. A specific follow-up during childhood may be useful to confirm if such abnormal
testis development is common in young boys with MPS IH and if it may lead to precocious onset of puberty in
survivors despite HSCT. Furthermore, we have observed that Sertoli cell maturation (up-regulation of AR expression,
down-regulation of AMH expression) occurred before the clinical signs of puberty and before the increase of
testosterone plasmatic level.
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La Mucopolysaccharidose de type IH (MPS IH) est une maladie rare lysosomale de transmission récessive
autosomique. L’allogreffe de cellules souches hématopoïétiques (CSH) a été proposée pour le traitement des
patients atteints de MPS IH et offre la possibilité d’une survie de ces patients jusqu’à l’âge adulte. La puberté
précoce a été décrite chez quelques patients MPS. Nous rapportons, à notre connaissance et pour la première fois,
l’initiation de la première vague de spermatogenèse observée fortuitement dans les tubules séminifères d’un
garçon de 19 mois, atteint de MPS IH et sans signes cliniques de puberté précoce. Ce patient a bénéficié d’une
cryoconservation de tissu testiculaire avant la greffe de CHS. Le diamètre des tubes séminifères, la différenciation
des cellules germinales et l’expression du récepteur aux androgènes et de l’hormone antimüllérienne dans les
cellules de Sertoli présentent les caractéristiques retrouvées dans le testicule d’un garçon pubère. Le syndrome de
Hurler peut être responsable de l’initiation précoce de la spermatogenèse. Un suivi spécifique pendant l’enfance
peut être utile pour confirmer si cette maturation prématurée du testicule est fréquente chez les jeunes garçons
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atteints de MPS IH et si elle peut conduire à une puberté précoce chez les patients malgré la greffe de CSH. En
outre, notre observation démontre que la maturation des cellules de Sertoli se produit avant les signes cliniques de
puberté et avant l’augmentation de la concentration plasmatique de testostérone.
Mots clés: Récepteur aux androgènes, Hormone anti-müllérienne, Syndrome de Hurler, Spermatogenèse,
Tissu testiculaireBackground
Hurler syndrome (HS), or mucopolysaccharidosis type
IH (MPS IH), is a rare autosomal recessive lysosomal
storage disorder, due to α-L-iduronidase activity defi-
ciency, enzyme required for the breakdown of the gly-
cosaminoglycans (GAG) heparan and dermatan sulfates
[1]. MPS IH clinical phenotype is due to an excessive
accumulation of GAG in lysosomes of affected organs.
Clinical signs usually appear before the age of 2 years
and the median survival is 6.8 years without any treat-
ment [2]. Enzyme replacement therapy and haematopoi-
etic stem cell transplantation (HSCT) are the treatment
proposed in MPS IH and offer the chance for children
with MPS IH to grow into their adulthood. Consequently,
long-term outcomes and complications have become clin-
ically relevant [3-6].
Central precocious puberty (CPP) [7] has been excep-
tionally described in patients with type IH or IIIA MPS
[8-10] and central nervous system organic lesions are
frequently observed within this context [11].
We report, for the first time and to the best of our
knowledge, the fortuitous observation of precocious initi-
ation of the first waves of spermatogenesis in a pre-
pubertal 19-month-old boy with MPS IH who underwent
testicular tissue cryobanking before HSCT, in order to
preserve his future fertility. Spermatogenesis was com-
pared with data obtained in four boys, aged between 1 and
17 years, who cryopreserved testicular tissue within the
context of non-malignant disease.Case presentation
Patient
Our HS patient was the first child of healthy non-
consanguineous parents. MPS IH was diagnosed at 15
months, due to cornea clouding, inguinal hernia, re-
spiratory disorders, hepatosplenomegalia and dorsal ky-
phosis. Brain magnetic resonance imaging revealed mild
ventricular enlargement and cystic areas of corpus callo-
sum splenium region. Deficiency of α-L-iduronidase ac-
tivity with two missense mutations of the gene (W402X
and M504R) confirmed the diagnosis. The patient received
enzyme replacement therapy and HSCT was performed at
20 months. Testicular tissue cryopreservation was pro-
posed before HSCT and the patient did not exhibit any
clinical signs of puberty (Tanner 1 stage) [12].Plasma Luteinising Hormone (LH) and Follicle-Stimulating
Hormone (FSH) were measured by chemiluminescent
immunoassay (Immulite 2500, Siemes Healthcare Diag-
nostics), testosterone by radioimmunoassay (in duplicate)
(Immunotech Beckman-Coulter, Marseille, France), in-
hibin B by ELISA (Ge II ELISA Beckman Coulter) as
well as Anti-Müllerian Hormone (AMH) by immuno-
assay (EIA Immunotech Beckman-Coulter). The lower
limit of sensitivity for LH and FSH was 0.1 IU/l. The de-
tection limit was 0.1 ng/ml for testosterone, 2.6 pg/ml
for inhibin B and 1 ng/ml for AMH.
At the time of the biopsy (19 months), the plasmatic
levels of inhibin B and AMH were increased. After HSCT,
basal plasmatic FSH level was higher than the 95 percent-
ile for pre-pubertal normal boys (Tanner stage I). How-
ever, LH, testosterone, inhibin B and AMH levels were
normal (Table 1).
Testicular tissue samples
Four boys, aged between 1 and 17 years, who cryobanked
testicular tissue due to non-malignant disease, were con-
sidered as controls (C) for the histological analysis of tes-
ticular tissue. These controls (C1, C2, C3 and C4) were
not previously exposed to gonadotoxic treatment before
testicular tissue banking and they presented thrombopae-
nia (C1), drepanocytosis (C2), aplastic anaemia (C3) and
torsion of the left testis (C4) respectively. Parents or legal
guardians signed an informed consent for testicular tissue
cryopreservation, analysis of the tissue and publication of
data collection. Our study respects the current bioethics
French law for the preservation of germinal tissue.
Testicular tissue preparation
A bilateral testicular biopsy was performed under general
anaesthesia and was cut into 10 mg fragments. The tes-
ticular fragments were placed into cryovials containing the
cryoprotective medium and were frozen using a controlled
slow freezing protocol without seeding in a programmable
freezer (Freezal®, Air Liquide, Paris, France), before
transfer into liquid nitrogen [13,14]. One fragment of
each biopsy was fixed in Bouin’s solution and was used
for histological evaluation. Ten sections (4 μm) of each
testis were cut at 20 μm intervals and stained with
haematoxylin-eosin-saffron (HES) or processed for im-
munochemistry. Observations were performed using a
Table 1 Hormonal findings before (at the time of the biopsy) and after haematopoietic stem cell transplantation
(HSCT) of the Hurler syndrome patient * [32]
Age (years) FSH basal (mUI/ml) LH basal (mUI/ml) Testosterone basal (ng/ml) AMH (ng/ml) Inhibin B (pg/ml)
Before HSCT 1.8 0.47 0.27 0.1 121.2 239
After HSCT 2.2 2.6 0.3 <0.1 57.8 112
Normal values 1.5 0.1-2.5 0.2-2.95 <0.3 51.38-88.34 <182*
1yr                1.8yr                   9yr                 12yr                 17yr
Figure 1 Mean seminiferous cord size of the Hurler syndrome
patient and controls according to the age at the time of the
testicular biopsy. Data are presented as mean±standard
deviation (SD).
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tem, Solms, Germany) with serial digital images recorded
at × 1000 magnification. The results were expressed as the
mean of the data obtained from the two testes for all the
evaluated parameters.
Histological analysis of testicular tissue
The mean diameter and area of 30 cross-sectioned sem-
iniferous tubules were determined using a digital image
analysis system (LAS 2.8.1, Leica, Solms, Germany). A
tubule was defined as cross-sectioned when the ratio
between the longest diameter and the diameter per-
pendicular to the longest one was evaluated between 1
and 1.5.
Five-micrometer sections of paraffin-embedded tissue
were boiled for 40 min in 0.01M-citrate buffer, pH 6
(S2031, Dako, Trappes, France). Slides were incubated
for 5 min in HP block solution (S2023, Dako, France)
and overnight at 4°C with (i) 1:100 of rabbit anti- An-
drogen Receptor (AR) primary antibody (sc-816, Santa
Cruz, CA, USA), or (ii) 1:50 of goat anti-AMH primary
antibody (6886, Santa Cruz, CA, USA), or (iii) 1:50 of
rabbit anti 3β-hydroxysteroid dehydrogenase (3β-HSD)
(E-0353, Dako, Les Ulis, France) or 25 min at room
temperature (RT) with 1:300 of mouse anti-Vimentin pri-
mary antibody (M0725, Dako, Trappes, France). Bound
antibody was detected using an avidin biotin complex and
3.3′-diaminobenzidine (K5001, Dako, Trappes, France).
Negative controls were obtained by omitting primary anti-
body. Stained cells were counterstained with Haematoxylin
(Dako, France) and analysed under a light microscope (DM
4000 B, LEICA, Solms, Germany) at ×400 magnification.
AMH labelling was scored according to the staining
intensity and the proportion of intra-tubular stained
area. AR labelling was scored for myoid, Leydig and Sertoli
cells according to the intensity and the proportion of
stained cells. Sertoli cell maturity was qualitatively assessed
as follows: (i) following AMH labelling, the Sertoli cells
were considered to be infantile for complete intratubular
area staining, intermediate for partial staining and in post-
pubertal state for negative staining, (ii) following AR label-
ling, the Sertoli cells were considered to be in an infantile
state if no staining was observed, in an intermediate state
if a cytoplasmic staining was detected and in post-pubertal
state if intense Sertoli cell nuclear staining was observed,(iii) following vimentine labelling, Sertoli cell morphology
was considered to be infantile if the nuclei were round to
ovoid with one or two small nucleoli and post-pubertal if
the nuclei were most often triangle-shaped, with a large,
centrally located nucleolus [15,16].
Results
The tubule diameter increased with age in controls and
was comprised between the values observed in the 12
and 17-year-old controls, in our HS patient (Figures 1
and 2A1, B1, C1, D1 and E1).
Spermatocytes I were detected in 7.8% of seminiferous
cord sections in our HS patient (Figures 3 and 2D2). Mei-
otic germ cells represented 0.9% of intra-tubular cells.
Germ cell differentiation up to the spermatocyte I stage
was not observed in the seminiferous tubules of the youn-
gest pre-pubertal controls (1 and 9-year-old controls re-
spectively, Figures 3 and 2A2 and B2) and was only
identified in 2.4% of tubules of the 12-year-old patient
with germ cells at pachytene stage representing 0.2% of
intra-tubular cells (Figures 3 and 2C2). For the 17-year-
old patient, 67.5% of intra tubular cells were meiotic germ
cells (Figure 2E2).
For the Hurler patient and the controls, AR was al-
ways expressed in Leydig and myoid cells. Furthermore,














































Figure 2 Sertoli cell immuno-labelling of vimentine [1 and 2], anti-Müllerian hormone [3], androgen receptor [4] and Leydig cell
immuno-labelling of 3β HSD: 3β-hydroxysteroid dehydrogenase [5] in seminiferous tubules of the Hurler syndrome patient [D] and 1.8
[C1 – A], 9 [C2 – B], 12 [C3 – C] and 17 [C4 – E] -year-old controls respectively. Sertoli cells with positive expression of (i) cytoplasmic
vimentine or AMH as well as (ii) nucleic AR, are brown stained. For Hurler patient and controls, AR was always expressed in Leydig and myoid
cells. AR could be detected in Sertoli cells only at the onset of puberty [C4 and E4] and in our patient [D4]. AMH was strongly expressed for the
youngest control [A3], weakly expressed for our Hurler patient [D3] and undetectable for the oldest control [E3]. 3β-HSD was weakly expressed in
Leydig cells of the Hurler patient [F3], moderately expressed at the onset of puberty [B5 and C5] and highly expressed in the oldest control [E5].
Scale bar: (1, 3, 4) 50 μm, (2) 30 μm. Footnotes: AMH: Anti-Müllerian Hormone - AR: Androgen Receptor - 3β-HSD: 3β-hydroxysteroid dehydrogen-
ase - C: Control - Es: Elongated spermatid - Sg: Spermatogonia - Sp I: Spermatocyte I - St: Sertoli cell - Vim: Vimentine - y: years.
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year control. Our patient presented a major nuclear ex-
pression of AR (Figure 2A4, B4, C4 and E4). Moreover,
AMH was strongly expressed in Sertoli cells of the
youngest controls (C1, C2 and C3), weakly expressed in
our Hurler patient and was undetectable in the oldest
control (C4) (Figure 2A3, B3, C3, D3 and E3). However,
most of Sertoli cell nuclei of our patient had an infantile
morphological aspect with one or two small nucleoli and
a rounded or ovoid shape. According to these criteria,
Sertoli cell maturity of our Hurler patient was compar-
able to the 12-year-old control (C3). The expression of
3β-HSD was confined to the cytoplasm of the Leydig
cells, was relatively intense in C2 and C3 controls and
markedly expressed in pubertal C4 control but was notdetectable in the youngest C1 control. Leydig cells of our
Hurler patient expressed moderately 3β-HSD (Figure 2A5,
B5, C5, D5 and E5).
Discussion and conclusion
Our study explored, to the best of our knowledge and
for the first time, the testicular development of a pre-
pubertal patient with mucopolysaccharidosis that revealed
a precocious initiation of spermatogenesis. Seminiferous
tubules presented histological modifications observed
normally in seminiferous tubules of boys during the ini-
tiation of the first waves of spermatogenesis. However,
the plasmatic hormonal profile of our patient was not in
agreement with the histological features of seminiferous
tubules because the plasmatic level of inhibin B was
1yr                  1.8yr                    9yr                   12yr                  17yr
Figure 3 Percentages of tubules with germ cell differentiation
evaluated in seminiferous tubules of the Hurler syndrome
patient and controls according to the age at the time of
testicular biopsy.
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of AMH remained moderately increased. After HSCT,
FSH increased slightly while inhibin B and AMH de-
creased significantly (Table 1).
Between birth and the onset of puberty in humans,
seminiferous tubules do not usually show major changes.
Tubular diameter remains stable (~50-60 μm) [17]; Ser-
toli cells show typically immature features with oval and
elongated nuclei associated to a regular shape [16] and a
high level of AMH expression [18]; AR is not or slightly
expressed in Sertoli cells [19]; furthermore, germ cell
population, initially represented by gonocytes and subse-
quently by spermatogonia, proliferates by mitosis [20].
However, the pre-pubertal testis should not be consid-
ered as a quiescent organ because the testis exhibits nu-
merous changes during infancy to prepare the pubertal
maturation [21]. During the pubertal development, the
enlargement of testicular size relies mainly on the in-
crease of seminiferous tubule volume depending on the
tubule diameter and the tubular length. Testis volume is
directly dependant on germ cell proliferation and Sertoli
cell number [22]. The tubular diameter observed in our
patient corresponded to a tubular diameter of a testis dur-
ing the pubertal development when compared with con-
trols. It is well established that testicular volume closely
correlates with the degree of testicular maturation.
Meiotic germ cells were detected in seminiferous tu-
bules of our HS patient. Primary spermatocytes had yet
been observed in seminiferous tubules of 4, 8 and 9-year-
old pre-pubertal normal boys, but never in boys aged less
than 2 years [23]. During the normal development of the
testicle, a marked proliferation of spermatogonia occurs
at 3-4 and 8-9 years [24-26], generally interpreted as
premature failed attempts of spermatogenesis initiation.At about 4 and 9 years, a slight increase of FSH plas-
matic level that might be involved in the initiation of
the meiotic process has also been reported [27,28]. This
incomplete achievement of the spermatogenetic process
may be related not solely to an insufficient production
of testosterone [29] but also to an immature status of
Sertoli cell. Our HS patient should be an example of
such physiological process but these data would not explain
the premature modification of AR and AMH expression in
Sertoli cells.
At the onset of puberty, testosterone induces Sertoli
cell morphological [30] and functional maturation with a
significant decrease of AMH expression [31] and a highly
expression of AR [19]. In our patient, 3β-HSD, a typical
marker of Leydig cell precursors or mature Leydig cells,
was moderately expressed in the interstitial compartment.
These data confirmed the hypothesis of a probable discrete
rise in intra-testicular testosterone due to a probable pre-
mature maturation of Leydig cell function, even if the tes-
tosterone blood level was not increased in our patient.
This discrete amount of testosterone promotes the matur-
ation of Sertoli cells, the initiation of spermatogenesis and
the increase of seminiferous tubule diameter, as observed
in our patient [21,22]. During the physiological onset of
puberty, intra-testicular testosterone level increases more
precociously than its plasmatic level [22].
In addition, Sertoli cells of our patient maintained an
infantile morphology, as for C3 control boy considered
at the onset of puberty, [15] but a level of expression of
AMH and AR close to mature Sertoli cells. Therefore,
AMH was weakly expressed and AR was markedly de-
tected. Moreover, inhibin B produced by Sertoli cells
and known to be significantly increased at pubertal stage
II compared with pre-pubertal period (stage I) [32] was
measured at a high concentration in the plasma of our
patient before HSCT. Our patient did not present any
clinical signs of precocious puberty with no enlargement
of testicular size but this parameter was indirectly
assessed using manual palpation. In a few published re-
ports, precocious puberty was diagnosed or suspected in
4 (15%) out of 27 young males and females with HS after
HSCT. Two 7-year-old girls had clinical signs of preco-
cious puberty and the two other patients, sex not men-
tioned, presented biochemical hormonal plasmatic profile
consistent with a precocious puberty [10]. In addition,
precocious puberty has been yet reported in five boys with
type IIIA mucopolysaccharidosis. Precocious puberty was
diagnosed between 5.9 to 9.6 years. Basal LH and testos-
terone plasmatic levels were always increased and basal
FSH plasmatic level was elevated for four patients [8,9].
A lesion of the central nervous system has been de-
tected in 94% of boys with central precocious puberty
(CPP) [11]. Hurler syndrome induced alterations of the
central nervous system such as cystic areas in the centrum
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or pericallosal region [33] and ventricular enlargement
with communicating hydrocephalus in advanced stages
[34]. The accumulation of glycosaminoglycans may cause
CPP by interfering with neural pathways that inhibit
Gonadotropin Releasing Hormon (GnRH) generation,
by acting on the hypothalamus or the pituitary gland
through an increased intracranial pressure [7] and by
disturbing the activity of several cytokines involved in
GnRH regulation [35,36].
In our report, the basal LH, FSH and testosterone
blood levels were not increased at the time of the biopsy
and we did not have any complementary data from the
follow-up showing an activation of the GnRH neuron in
our patient. Therefore, it is difficult to conclude that gly-
cosaminoglycans overproduction and central nervous
system lesions may have activated the hypothalamic-
pituitary-gonadal axis, responsible for the premature ini-
tiation of spermatogenesis. A local effect induced by the
heparane sulphate accumulation is also possible. Indeed,
the proteoglycans are present in the seminiferous tubule
basement membrane [37] and in the membrane of Ser-
toli cells [38]. The function of the proteoglycans remains
to be cleared up, but we know, for example, that sperm-
atogonia and Sertoli cells require follistatin to modulate
the actions of activin A during the development of the
testicle [39] and that the active form of follistatin binds
to the cell surfaces or the basement membranes with a
strong affinity for proteoglycans [40].
Clinical and biochemical follow-up of our patient may
contribute to determine if the abnormal histological fea-
ture observed in seminiferous tubules that did not cor-
respond to the physiological age of our HS patient is
predictive of CCP. CCP treatment is indicated to pre-
vent progression of puberty. Thus, GnRHa therapy in
two patients affected by MPS type IIIA had a beneficial
effect on height but also on behavioural problems such
as hyperactivity, destructive behaviour and sleep distur-
bances [9].
Testicular tissue banking of HS patients performed be-
fore HSCT, may allow fertility preservation but can also
be useful for the detection of an abnormal gonad devel-
opment and to plan hormonal therapy if necessary.
However, this genetic disease remains exceptional. Our
case report also confirms that Sertoli cell maturation ob-
served at the initiation of spermatogenesis precedes the
elevation of testosterone plasmatic level and the clinical
signs of puberty.Consent
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